Target Name: GAS2
NCBI ID: G2620
Review Report on GAS2 Target / Biomarker Content of Review Report on GAS2 Target / Biomarker
GAS2
Other Name(s): GAS-2 | GAS2_HUMAN | growth arrest specific 2 | Growth arrest specific 2, transcript variant 3 | Growth arrest-specific protein 2 | MGC32610 | Growth arrest-specific protein 2 (isoform a) | Growth arrest-specific 2 (GAS2) | GAS2 variant 3

GAS2: Potential Drug Target Or Biomarker

GAS2, or GAS-2 protein, is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the GAS family of proteins, which are involved in a variety of cellular processes, including cellular signaling, DNA replication, and inflammation. GAS2 has been shown to play a role in the regulation of cell proliferation and has potential as a drug target or biomarker.

GAS2 is involved in a variety of cellular signaling pathways, including the regulation of cell proliferation, apoptosis (programmed cell death), and cell-cell adhesion. It has been shown to play a role in the regulation of cell cycle progression, with studies showing that GAS2 can inhibit the G1 phase of the cell cycle and promote the G2 phase. This means that GAS2 can delay the cell cycle and encourage the cell to enter a state of growth and division.

In addition to its role in cell proliferation, GAS2 has also been shown to play a role in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. GAS2 has been shown to be involved in the regulation of cell apoptosis, with studies showing that GAS2 can induce cell apoptosis in a variety of cell types. This means that GAS2 can be used as a potential drug target or biomarker for diseases that are characterized by the loss of cell life.

Another area of research that has relevance to GAS2 is its role in cell-cell adhesion. Cell-cell adhesion is the process by which cells stick together to form tissues and organs. GAS2 has been shown to play a role in the regulation of cell-cell adhesion, with studies showing that GAS2 can interact with other proteins that are involved in cell-cell adhesion. This means that GAS2 can be involved in the development and maintenance of tissue structure and can potentially be targeted by drugs that are designed to disrupt cell-cell adhesion.

GAS2 has also been shown to play a role in the regulation of inflammation. Inflammation is a natural response of the immune system to the presence of foreign substances in the body. GAS2 has been shown to be involved in the regulation of inflammation, with studies showing that GAS2 can inhibit the production of pro-inflammatory cytokines. This means that GAS2 can be used as a potential drug target or biomarker for diseases that are characterized by the production of pro-inflammatory cytokines.

Despite its potential as a drug target or biomarker, GAS2 has not yet been fully studied. There are only a few studies that have investigated the role of GAS2 in cell biology and its potential as a drug target or biomarker. Further research is needed to fully understand the role of GAS2 in cell biology and its potential as a drug target or biomarker.

In conclusion, GAS2 is a protein that is involved in a variety of cellular processes in the body. It has been shown to play a role in the regulation of cell proliferation, apoptosis, and cell-cell adhesion, as well as the regulation of inflammation. Further research is needed to fully understand the role of GAS2 in cell biology and its potential as a drug target or biomarker. If its potential as a drug target or biomarker is confirmed, GAS2 may have a valuable role in the development of new treatments for a variety of diseases.

Protein Name: Growth Arrest Specific 2

Functions: May play a role in apoptosis by acting as a cell death substrate for caspases. Is cleaved during apoptosis and the cleaved form induces dramatic rearrangements of the actin cytoskeleton and potent changes in the shape of the affected cells. May be involved in the membrane ruffling process (By similarity)

The "GAS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GAS2L1 | GAS2L2 | GAS2L3 | GAS5 | GAS6 | GAS6-AS1 | GAS7 | GAS8 | GAS8-AS1 | GASAL1 | GASK1A | GASK1B | GASK1B-AS1 | GAST | GATA1 | GATA2 | GATA2-AS1 | GATA3 | GATA3-AS1 | GATA4 | GATA5 | GATA6 | GATA6-AS1 | GATAD1 | GATAD2A | GATAD2B | GATB | GATC | GATD1 | GATD1-DT | GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH | GCFC2 | GCG | GCGR | GCH1 | GCHFR | GCK | GCKR | GCLC | GCLM | GCM1 | GCM2 | GCN1 | GCNA | GCNT1 | GCNT1P3 | GCNT2 | GCNT3 | GCNT4 | GCNT7 | GCOM1 | GCSAM | GCSAML | GCSAML-AS1 | GCSH | GCSHP3 | GCSIR | GDA | GDAP1 | GDAP1L1 | GDAP2 | GDE1 | GDF1 | GDF10 | GDF11 | GDF15 | GDF2 | GDF3 | GDF5 | GDF6 | GDF7 | GDF9 | GDI1